Table of Contents
Diabetes is currently the eighth leading cause of death and disability worldwide, with approximately 500 million people suffering from the disease. The prevalence of diabetes is also expected to increase, with the total number of diagnosed cases estimated to reach 1.31 billion by 2050. As diabetes is a major public health concern worldwide, developing strategies to control risk factors is crucial.1
At the Endocrine Society's 2024 Annual Meeting, held June 1-4 in Boston, Massachusetts, four posters were presented that delved deeper into diabetes, examining the effects of long COVID, increased fracture risk, the role of low-density lipoprotein (LDL) cholesterol in diabetes development, and the effectiveness of liraglutide in reducing cardiovascular complications.
For more ENDO 2024 coverage, click here
Pharmacy work is constantly changing. To stay ahead of the curve, Free Drug Topics Newsletter Get the latest drug information, industry trends, and patient care tips delivered straight to your inbox.